The Food and Drug Administration approved Aratana Therapeutics Inc.'s (Nasdaq: PETX) treatment for osteoarthritis pain and inflammation in dogs lifting the stock price 68 cents to close at $5.19.
FDA approves Aratana's osteoarthritis treatment
March 21, 2016 at 17:40 PM EDT
